Shares of Cano Health, Inc. (NYSE: CANO) surged in after-hours trading Friday as the company announced a change in its executive leadership to advance its strategy for stockholder value creation. 

Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and will continue serving on the Board of Directors. Mark Kent, the current Chief Strategy Officer, has been appointed as the Interim Chief Executive Officer while the company conducts an external search for a permanent successor.

The Board also plans to refresh its membership by adding new independent directors to enhance capabilities and optimize performance. 

The announcement has been received positively, with $CANO trading at $1.57 (+25.60%) in after-hours following the news.

Lennar Corporation (NYSE: LEN) received positive assessments and price target upgrades from multiple analyst firms. 

Evercore ISI Group maintained an Outperform rating and increased the price target from $153 to $161. BTIG maintained a Buy rating and raised the price target from $120 to $148. Furthermore, JMP Securities reiterated a Market Outperform rating and raised the price target from $115 to $135 for Lennar.

On Friday, $LEN closed at $120.02, reflecting a slight increase of $0.21 (+0.18%). 

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)